What if the key to saving lives in maternal health wasn't more hospital visits—but smarter, connected care at home?

In this episode of Med Tech Gurus, we sit down with Anish Sebastian, Co-Founder and CEO of BabyScripts, the leading virtual care platform transforming how mothers and providers navigate pregnancy. Built from both analytics and empathy, BabyScripts bridges one of healthcare's most critical gaps—access to consistent, quality prenatal and postpartum care

Under Anish's leadership, BabyScripts has raised over $30 million in funding from partners like Philips and Cigna, now managing over 300,000 pregnancies across more than 70 health systems. From detecting preeclampsia early to supporting mental health and postpartum recovery, the platform delivers measurable results—proving that technology and teamwork can make pregnancy safer for every mother.

Anish shares his insights on scaling digital health, building strategic partnerships, and leveraging AI to expand maternal care equity. Whether you're an entrepreneur, innovator, or clinician, this episode reveals how connected technology can deliver life-changing outcomes at scale.

What if we could take the guesswork out of cancer treatment—and move from try and hope to test and know?

In this episode of Med Tech Gurus, we sit down with Jim Foote, CEO and Founder of First Ascent Biomedical, whose mission began after losing his son to cancer. That experience became the driving force behind Functional Precision Medicine (FPM)—a groundbreaking approach that combines tumor testing, genomics, and AI to rank the most effective drugs for each patient in just ten days

Backed by a Nature Medicine study showing an 83% patient benefit rate, First Ascent is proving that personalization saves lives. With automation reducing lab times from hours to minutes and new CLIA-certified labs accelerating access, Jim and his team are reshaping how cancer care is delivered.

From building trust with clinicians to leading through loss, Jim shares a powerful story of innovation, resilience, and purpose that every medtech leader can learn from.

What if trauma care didn't require a full surgical team or a giant toolbox to save lives in critical moments? In this episode of Med Tech Gurus, Dr. Adam Power, vascular surgeon and co-founder of Frontline Medical Technologies, takes us inside the development of the COBRA-OS—an ultra-simplified REBOA device that's transforming trauma care.

From war zones to rural communities, Dr. Power explains how miniaturization and smart design make this innovation faster, safer, and more accessible—without sacrificing patient outcomes. We discuss the challenges of commercialization, academic innovation, and the evolving role of physicians as entrepreneurs. Gurus, this episode is a masterclass in turning front-line insight into global impact. Don't miss it!

What if the missing link in treating autoimmune disease wasn't a new drug—but a better way to measure stress?

In this episode of Med Tech Gurus, we sit down with Dr. Andrew Holman, CEO of Inmedix and the innovator behind CloudHRV, the first FDA-cleared platform to measure stress biology with medical-grade precision

.At a time when 75% of autoimmune treatments fail—costing billions and leaving patients without answers—CloudHRV delivers actionable insights in just five minutes reframing how clinicians think about chronic disease.

Dr. Holman takes us inside his two-decade journey building Inmedix, from early IP strategy to securing partnerships with global pharma. Along the way, he shares lessons on leveraging licensing as a growth strategy, building a culture of innovation, and aligning science, business, and patient care in the pursuit of transformative healthcare solutions.

Whether you're a founder, investor, or clinician, this conversation will reshape how you think about precision medicine and the future of patient-centered innovation.

What happens when one of the toughest challenges in vascular medicine—severe arterial calcification—meets breakthrough engineering?

In this episode of Med Tech Gurus, we sit down with Dr. Robert Chisena, Co-Founder and CTO of Amplitude Vascular Systems (AVS). With a PhD in mechanical engineering and a portfolio of five patents, Robert has dedicated his career to tackling one of the most stubborn barriers in cardiovascular health: hardened arterial blockages that resist traditional interventions.

From the labs at the University of Michigan to the founding of AVS, Robert shares how he and his team are developing a next-generation intravascular lithotripsy platform designed to fracture calcium safely and effectively—combining the familiarity of angioplasty with the power of shockwave technology. Along the way, he offers lessons on building IP-rich startups, fostering innovation cultures, securing clinical adoption, and navigating the high-stakes path from spinout to commercialization

Whether you're an engineer, entrepreneur, or investor in medtech, this conversation shines a light on the strategies, setbacks, and breakthroughs required to transform a complex clinical challenge into a scalable, life-saving solution.

What if solving a widespread medical condition didn't require surgery, expensive implants, or harsh medications—but could be done by simply putting on a sock?

In this episode of Med Tech Gurus, we sit down with Isaac Oppenheim, CEO and Founder of Zida, a company pioneering wearable neuromodulation at the intersection of aging, textiles, and healthcare. Inspired by his grandfather's struggle with overactive bladder (OAB), Isaac developed the Zida Control Sock—the first FDA-cleared, Medicare-covered, home-use neuromodulation device for OAB.

From his early career in textiles and wearable tech with brands like Nike and Lululemon, to navigating FDA clearance and CMS reimbursement without institutional capital, Isaac's journey shows what happens when design thinking, perseverance, and patient-centered innovation come together. Clinical trials show nearly 80% success rates, giving millions of patients renewed confidence, independence, and quality of life

Whether you're an entrepreneur building medtech from scratch, a clinician seeking better therapies for aging populations, or an innovator curious about the future of neuromodulation, this episode is packed with lessons on resilience, creativity, and making healthcare more human.

What happens when groundbreaking medtech isn't enough—when success depends on how well physicians and health plans actually adopt it?

In this episode of Med Tech Gurus, we sit down with Dr. Shannon Decker, PhD, MBA, M.Ed., Founder & CEO of VBC1. With over 25 years of experience in healthcare transformation—including 17 years in Medicare, Medicaid, quality improvement, and risk adjustment—Shannon has become a nationally recognized strategist on aligning medical devices with real-world provider workflows.

From helping health plans and physician groups improve outcomes, to showing medtech innovators why the best devices still fail without strong provider enablement, Shannon shares hard-earned lessons on education, incentives, and adoption. She explains how startups can avoid costly mistakes, when to engage with clinicians, and why intrinsic motivation often drives lasting change more than financial incentives.

Whether you're a startup CEO, a commercial leader, or a clinician navigating the shift to value-based care, this conversation delivers a playbook for turning innovation into impact

What if the lines of code you wrote weren't just running a program—but keeping someone's heart beating?

In this episode of Med Tech Gurus, we sit down with Wade Demmer, Vice President of Research and Development for Cardiac Pacing Therapies at Medtronic, whose career journey began with his grandmother's pacemaker and led him to help pioneer some of the world's most impactful cardiac devices, including Micra, the world's smallest pacemaker.

Wade shares the lessons of two decades inside the world's largest medtech company—what it really takes to build a culture of innovation, engineer for reliability, and launch breakthrough devices at scale. From balancing patient safety with bold ideas, to recognizing when timing makes or breaks a technology, Wade brings a deeply personal and practical lens to the future of cardiac pacing and medtech innovation.

Whether you're an engineer, entrepreneur, or leader aiming to improve patients' lives, this conversation will expand how you think about risk, collaboration, and building technologies that truly matter